Related references
Note: Only part of the references are listed.
Article
Oncology
Rebecca L. Siegel et al.
Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.
CA-A CANCER JOURNAL FOR CLINICIANS
(2022)
Article
Oncology
Jin Hwa Hong et al.
Summary: This study conducted genomic profiling of patients with advanced endometrial cancer (EC) using targeted next-generation sequencing (NGS) and found that PPP2R1A mutations might be associated with a dismal prognosis in advanced EC.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Tao Jiang et al.
Summary: Camrelizumab plus chemotherapy has been shown to significantly improve the treatment outcomes for patients with advanced lung squamous cell carcinoma, but there is still a lack of predictive biomarkers.
Article
Oncology
Hao Wen et al.
Summary: This study revealed the unique genomic profile of Chinese patients with cervical cancer and identified prevalent actionable variants related to the PI3K and DDR pathways. DDR alteration exerted significant influence on the tumor microenvironment in cervical cancer, guiding clinical decisions for treatment. CDHR5 was the first identified hub gene negatively correlated with DDR or hypoxia in cervical cancer.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Shan Zhu et al.
Summary: This study investigates the genomic alterations and T cell repertoire of the five major histotypes of epithelial ovarian cancer (EOC). It identifies distinct characteristics and higher T cell clonality in clear cell ovarian cancer (CCOC), which is associated with more sensitive anti-tumor responses.
Article
Oncology
Yunuo Zhang et al.
Summary: This study investigated the prevalence and spectrum of BRCA1 and BRCA2 mutations in Chinese Hakka patients with breast and ovarian cancer. The results showed that the most common pathogenic variants in this population were c.2635G > T in the BRCA1 gene and c.5164_5165delAG in the BRCA2 gene. The prevalence and spectrum of variants in the BRCA genes in the Hakka patients from southern China are different from those in other ethnic groups.
Editorial Material
Primary Health Care
Jennifer C. Davies-Oliveira et al.
BRITISH JOURNAL OF GENERAL PRACTICE
(2022)
Review
Oncology
Taher Daoud et al.
Summary: Gynecologic malignancies are common cancers in women worldwide, and early detection, accurate staging, and early detection of recurrence are crucial for management and patient survival. Various imaging techniques, including ultrasound, CT, MRI, and PET-CT, play important roles in the detection, characterization, staging, and restaging of cervical, endometrial, and ovarian malignancies. Recent advances in imaging, such as functional MRI and hybrid imaging with PET/MRI, contribute to lesion specification and the overall role of imaging in gynecologic malignancies. Radiomics, a new approach, aims to enhance decision support by extracting quantitative information from radiological imaging.
Review
Environmental Sciences
Sidrah Shah et al.
Summary: Epithelial ovarian cancer (EOC) is significantly influenced by hereditary factors, with a number of genes encoding proteins involved in the DNA mismatch repair (MMR) pathway. PVs in BRCA1 and BRCA2 genes contribute to a substantial fraction of hereditary EOC, while PV genes in the MMR pathway account for 10-15%. Identifying HR-deficient EOC patients has important implications for clinical treatment planning and targeted therapies.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Review
Obstetrics & Gynecology
Emma Lund Johansen et al.
Summary: This study reviews the historical perspective of germline pathogenic variants related to ovarian cancer and identifies several genes associated with an increased risk. In Denmark, at least ten genes are included in the screening panel for hereditary ovarian cancer.
GYNECOLOGIC ONCOLOGY REPORTS
(2022)
Article
Immunology
Haoyu Wang et al.
Summary: This study developed a novel TMB-related risk model (TMBrisk) to predict the prognosis of ovarian cancer (OC) patients and explored the association between TMB/TMBrisk and immune infiltration. The results showed that higher TMB and TMBrisk were associated with better survival and higher immune cell infiltration. The high TMBrisk group had higher-grade and advanced stage tumors. Meanwhile, higher TMBrisk was associated with an immunosuppressive phenotype, with less infiltration of immune cells and less expression of HLA genes. The TMBrisk model can predict prognosis, evaluate immune infiltration, and discover new therapeutic regimens in OC.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Lubna Therachiyil et al.
Review
Biochemistry & Molecular Biology
Evgeny Imyanitov et al.
Summary: In oncology practice, clinical decisions often rely on the detection of genetic alterations. Microsatellite instability (MSI) analysis identifies tumors with a high mutation rate, homologous repair deficiency (HRD) indicates tumor sensitivity to certain drugs, and tumor mutation burden (TMB) is a potential indicator of tumor response to immunotherapy. However, the applications of these tests in different cancer types require further research and standardization.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Multidisciplinary Sciences
Xiaoli Wang et al.
Summary: The authors report the human papillomavirus features and genomic landscape in small cell cervical carcinoma (SCCC) using high-throughput sequencing methods. They identify MYC, SOX, NR4A, ANKRD, and CEA family genes as HPV-integrated hotspots. In addition, they discover prominent HPV integration patterns and canonical cancer genes associated with focal copy number amplification peaks. These findings may contribute to the accurate diagnosis and effective treatment of SCCC.
NATURE COMMUNICATIONS
(2022)
Review
Pharmacology & Pharmacy
Nannan Wang et al.
Summary: Breast cancer and gynecological tumors pose significant risks to women's physical and mental health, fertility, and quality of life. While the prognosis and overall survival of cancer patients have improved due to standardized treatments, advanced disease management remains challenging. The clinical approval of poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis) has significantly improved the quality of life for breast and gynecological cancer patients, particularly those with BRCA1/2 mutations. However, drug resistance to PARPi therapy hinders its widespread use, necessitating the development of new drug strategies. This article reviews the mechanisms of PARPi resistance and current combination therapies that can enhance its effectiveness.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Oncology
Aarushi Audhut Caro et al.
Summary: This review provides an overview of current therapies for ovarian cancer, focusing on immunotherapies and the potential of dendritic cell vaccines. By highlighting different subsets of dendritic cells and their functions in ovarian cancer, we summarize the advancements and pitfalls of current dendritic cell vaccine strategies and discuss future perspectives for improving patient outcomes.
Review
Oncology
Fernando Cotait Maluf et al.
Summary: This article reports on the recommendations from an expert consensus meeting held to address the prevention and management of cervical cancer in limited resources countries. The meeting considered scientific evidence, practical experience, and cost-effectiveness in making their recommendations. Consensus was reached on some questions, but considerable heterogeneity was observed in others. The article discusses the challenges of implementing international guidelines in resource-limited or unique health-care settings.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Yang Li et al.
Summary: This study suggests that NGS-based subtyping can be an effective approach for molecular typing of EC. Both NGS and IHC have their own unique advantages and challenges in clinical practice.
ANNALS OF TRANSLATIONAL MEDICINE
(2022)
Article
Genetics & Heredity
Jing Liu et al.
Summary: This study analyzed the genomic alteration profiles and immune characteristics of Chinese cervical cancer patients. The results showed different molecular profiles and immune characteristics between squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the cervix. Certain gene mutations were identified as independent predictors of high tumor mutational burden (TMB) in cervical cancer. Furthermore, the study proposed the prognostic value of PTEN mutations.
BMC MEDICAL GENOMICS
(2022)
Article
Cell Biology
Ako Yokoi et al.
Summary: This study found that PTEN overexpression in endometrial carcinoma is associated with various cellular and molecular changes, including epithelial-mesenchymal transition, cellular senescence, apoptosis, migration capability, and cancer stem cell-like properties. In clinical samples, the PTEN score was positively correlated with the expression of molecules related to morular lesions and negatively correlated with cell proliferation. Furthermore, the expression of ERα/EBP50 acted as a negative regulator of morular formation by interacting with PTEN and beta-catenin.
CELL COMMUNICATION AND SIGNALING
(2022)
Review
Oncology
Ning Li et al.
Summary: Clinical trials using various PARP inhibitors have shown promising results for ovarian cancer patients. Fuzuloparib, developed by Jiangsu Hengrui Pharmaceuticals Co., Ltd., is a novel PARP inhibitor with higher stability and lower inter-individual variability than other inhibitors. Recent data from clinical trials provide insights into the efficacy and safety of fuzuloparib in treating advanced or recurrent ovarian cancer.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2022)
Review
Medicine, General & Internal
Chunbao Xie et al.
Summary: Breast cancer susceptibility gene 2 (BRCA2) is the main gene associated with hereditary breast cancers, but mutations in BRCA2 are also found in other types of tumors. This review discusses the biological functions of BRCA2 and the role of BRCA2 mutations in tumor progression and therapy.
Review
Medicine, General & Internal
Michihide Maeda et al.
Summary: Primary fallopian tube carcinoma has similar characteristics to ovarian carcinoma and rarely presents as an inguinal tumor. A review of literature on this rare type of carcinoma suggests a good prognosis for patients.
MEDICINA-LITHUANIA
(2022)
Article
Oncology
Lauren Clarfield et al.
Summary: Ovarian cancer is the leading cause of death among women with gynecologic malignancy. BRCA1 and BRCA2 germline mutations increase the risk of OC by 20 to 40 times compared to the general population. Effective screening methods for early detection of BRCA-associated OC are not available. This review summarizes the latest research on pharmacologic and surgical interventions for risk reduction in BRCA1/2 mutation carriers.
Article
Oncology
Yang Li et al.
Summary: This study utilized NGS panel for molecular subtyping of endometrial cancer, showing high specificity and sensitivity in detecting MSI and CN subtypes. Both NGS and IHC have their unique advantages and challenges in clinical practice.
ANNALS OF TRANSLATIONAL MEDICINE
(2022)
Article
Oncology
Rebecca L. Siegel et al.
Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.
CA-A CANCER JOURNAL FOR CLINICIANS
(2021)
Article
Oncology
Hyuna Sung et al.
Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.
CA-A CANCER JOURNAL FOR CLINICIANS
(2021)
Article
Medicine, Research & Experimental
Weiwei Feng et al.
Summary: The study demonstrated the effectiveness and stability of personalized ctDNA detection in high-risk EC patients for monitoring and predicting tumor recurrence. CtDNA tracking in post-operative plasma is valuable in predicting tumor relapse.
JOURNAL OF TRANSLATIONAL MEDICINE
(2021)
Article
Oncology
Richard S. P. Huang et al.
Summary: This study found genomic differences between PD-L1(positive) and PD-L1(negative) urothelial carcinomas, providing a framework for future clinical investigation. Additionally, differences in PD-L1 positivity based on sample collection sites were observed, which could influence sample selection for PD-L1 testing in patients with urothelial carcinoma.
Review
Oncology
Jenneke C. Kasius et al.
Summary: Endometrial cancer (EC) is the most common gynaecologic malignancy in developed countries, with the main challenge being to accurately estimate the risk of metastases at diagnosis and the risk of recurrence in the future. Molecular classification helps determine the risk of recurrence in patients and guides the choice of adjuvant treatment.
Article
Oncology
Andres Poveda et al.
Summary: Olaparib provided a median overall survival benefit of 12.9 months compared with placebo in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation. Although statistical significance was not reached, these findings are arguably clinically meaningful and support the use of maintenance olaparib in these patients.
Article
Medicine, Research & Experimental
Tao Jiang et al.
Summary: The study demonstrated that a high RS was associated with a higher objective response rate, longer progression-free survival, and overall survival. Changes in variant allele frequency (VAF) after two cycles of chemotherapy could predict treatment response. Monitoring VAF levels could provide valuable information for assessing treatment efficacy.
Article
Multidisciplinary Sciences
Kadi Lohmussaar et al.
NATURE COMMUNICATIONS
(2020)
Article
Oncology
Siwen Hu-Lieskovan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2020)
Review
Oncology
Anca Chelariu-Raicu et al.
CHINESE CLINICAL ONCOLOGY
(2020)
Review
Oncology
Malwina Suszynska et al.
GYNECOLOGIC ONCOLOGY
(2019)
Review
Oncology
Marina Stasenko et al.
JOURNAL OF ONCOLOGY PRACTICE
(2019)
Review
Medicine, General & Internal
Paul A. Cohen et al.
Article
Genetics & Heredity
Robert M. Samstein et al.
Review
Oncology
Mary Ellen Urick et al.
NATURE REVIEWS CANCER
(2019)
Article
Oncology
Cheng- Liao et al.
GYNECOLOGIC ONCOLOGY
(2018)
Article
Oncology
Min Chul Choi et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2018)
Article
Biochemistry & Molecular Biology
Konrad J. Karczewski et al.
NUCLEIC ACIDS RESEARCH
(2017)
Article
Oncology
Miranda M. Fidler et al.
Letter
Medicine, General & Internal
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2017)
Article
Genetics & Heredity
Zachary R. Chalmers et al.
Article
Biochemistry & Molecular Biology
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH
(2016)
Article
Multidisciplinary Sciences
Krishna L. Kanchi et al.
NATURE COMMUNICATIONS
(2014)
Article
Oncology
Inmaculada de Juan Jimenez et al.
Article
Medicine, General & Internal
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2012)
Article
Oncology
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY
(2011)
Article
Multidisciplinary Sciences
D. Bell et al.
Article
Radiology, Nuclear Medicine & Medical Imaging
Neeraj Lalwani et al.
Article
Oncology
Danielle Vicus et al.
GYNECOLOGIC ONCOLOGY
(2010)
Article
Biochemistry & Molecular Biology
Kai Wang et al.
NUCLEIC ACIDS RESEARCH
(2010)
